Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06460298
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-10
Brief Title:
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Sponsor:
ProDa BioTech LLC
Organization:
ProDa BioTech LLC
Organization Data
Organization:
ProDa BioTech LLC
Class:
INDUSTRY
Study ID:
BIO 01192022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ProDa BioTech LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Emory University | OTHER |
| Georgia State University | OTHER |